natgillin/translations-raw huggingface dataset:
Accordingly, the AFSSA Laboratory, Nancy operates the established proficiency testing procedure to appraise laboratories for authorisation to perform the serological tests.
Skladno s tem laboratorij AFSSA v Nancyju izvaja uveljavljen postopek testiranja ustreznosti za oceno laboratorijev, predlaganih za pooblastitev za izvajanje seroloških testov.
Commission Decision 2004/233/EC of 4 March 2004 authorising laboratories to check the effectiveness of vaccination against rabies in certain domestic carnivores [2], established a list of approved laboratories in the Member States on the ground of the results of the proficiency tests communicated by the AFSSA Laboratory, Nancy.
Odločba Komisije 2004/233/ES z dne 4. marca 2004 o odobritvi laboratorijev za preverjanje učinkovitosti cepljenja proti steklini pri nekaterih domačih mesojedih živalih [2] je uvedel seznam pooblaščenih laboratorijev v državah članicah na podlagi rezultatov postopka testiranja ustreznosti, ki jih je posredoval laboratorij AFSSA v Nancyju.
One laboratory in Czech Republic has been approved by the AFSSA Laboratory, Nancy, in compliance with Decision 2000/258/EC.
Laboratorij AFSSA v Nancyju je v skladu z Odločbo 2000/258/ES odobril laboratorij iz Češke republike.
Accordingly, it is appropriate to add this laboratory to the list of approved laboratories in the Member States as established in the Annex to Decision 2004/233/EC.
V skladu s tem je primerno dodati ta laboratorij na seznam pooblaščenih laboratorijev v državah članicah iz Priloge k Odločbi 2004/233/ES.
In Annex I to Decision 2004/233/EC, the section for the Czech Republic is replaced by the following:
V Prilogi I k Odločbi 2004/233/ES se oddelek za Češko nadomesti z naslednjim:
Done at Brussels, 14 September 2005.
V Bruslju, 14. septembra 2005
Decision as amended by Commission Decision 2003/60/EC (OJ L 23, 28.1.2003, p. 30).
Odločba, kakor je bila nazadnje spremenjena z Odločbo 2003/60/ES (UL L 23, 28.1.2003. str. 30).
Decision as last amended by Decision 2005/392/EC (OJ L 130, 24.5.2005, p. 17).
Odločba, kakor je bila nazadnje spremenjena z Odločbo 2005/392/ES (UL L 130, 24.5.2005. str. 17).
of 15 September 2005
z dne 15. septembra 2005
(notified under document number C(2005) 3441)
(notificirano pod dokumentarno številko K(2005) 3441)
Having regard to the Act of Accession of the Czech Republic, Estonia, Cyprus, Latvia, Lithuania, Hungary, Malta, Poland, Slovenia and Slovakia, and in particular Annex IX, Chapter 5, Section B, Subsection I, paragraph (d) thereto,
ob upoštevanju Akta o pristopu Češke, Estonije, Cipra, Latvije, Litve, Madžarske, Malte, Poljske, Slovenije in Slovaške ter zlasti odstavka (d) pododdelka I oddelka B poglavja 5 Priloge IX k Aktu,
Appendix B to Annex IX to the 2003 Act of Accession has been amended by Commission Decisions 2004/472/EC [1], 2004/473/EC [2] and 2005/421/EC [3].
Dodatek B k Prilogi IX k Aktu o pristopu iz leta 2003 je bil spremenjen z odločbami Komisije 2004/472/ES [1], 2004/473/ES [2] in 2005/421/ES [3].
According to an official declaration from the Lithuanian competent authority certain establishments in the meat, milk and fish sectors have completed their upgrading process and are now in full compliance with Community legislation.
Glede na uradno izjavo litovskega pristojnega organa so nekateri obrati v sektorjih mesa, mleka in rib zaključili postopek posodabljanja in so zdaj v celoti usklajeni s pravnimi akti Skupnosti.
Certain establishments have ceased their activities.
Nekateri obrati so prenehali opravljati svoje dejavnosti.
Those establishments should therefore be deleted from the list of establishments in transition.
Navedeni obrati se zato črtajo s seznama obratov v prehodu.
A limited number of establishments have made considerable efforts to comply with structural requirements laid down by Community legislation.
Nekateri obrati so vložili precej truda v to, da bi izpolnili strukturne zahteve, določene v pravnih aktih Skupnosti.
However these establishments are not in position to finish their upgrading process by the prescribed deadline due to exceptional technical constraints.
Vendar ti obrati zaradi izjemnih tehničnih omejitev ne bodo mogli zaključiti postopka posodabljanja v predpisanemu roku.
Appendix B to Annex IX to the 2003 Act of Accession should therefore be amended accordingly.
Dodatek B k Prilogi IX k Aktu o pristopu iz leta 2003 je zato treba ustrezno spremeniti.
Appendix B to Annex IX to the 2003 Act of Accession is replaced by the text in the Annex to this Decision.
Dodatek B k Prilogi IX k Aktu o pristopu iz leta 2003 se nadomesti z besedilom iz Priloge k tej odločbi.
Done at Brussels, 15 September 2005.
V Bruslju, 15. septembra 2005
OJ L 160, 30.4.2004, p. 62; corrected version in OJ L 212, 12.6.2004, p. 34.
UL L 160, 30.4.2004, str. 61; popravljena različica v UL L 212, 12.6.2004, str. 34.
OJ L 160, 30.4.2004, p. 68; corrected version in OJ L 212, 12.6.2004, p. 39.
UL L 160, 30.4.2004, str. 67; popravljena različica v UL L 212, 12.6.2004, str. 39.
OJ L 143, 7.6.2005, p. 38.
UL L 143, 7.6.2005, str. 38.
referred to in Chapter 5, Section B, Subsection I to Annex IX [1]List of establishments, including shortcomings and deadlines for the correction of these shortcomings
iz pododdelka I oddelka B poglavja 5 Priloge IX [1]Seznam obratov, vključno s pomanjkljivostmi in roki za njihovo odpravo
Meat establishments
Obrati za predelavo mesa
Vet.No
Vet. št.
UAB “Jatkančių mėsinė”, Jatkančių k., Tauragės r, Tauragės aps.
UAB ‚Jatkančių mėsinė‘, Jatkančių k., Tauragės r, Tauragės aps.
Annex I, Chapter I, point 4 (c)
točka 4(c) poglavja I Priloge I
Annex I, Chapter I, points 9, 11 and 12
točke 9, 11 in 12 poglavja I Priloge I
Annex I, Chapter II, point 14 (a), (b), (c), (e), (f), (g), (h), (k), and (l)
točka 14(a), (b), (c), (e), (f), (g), (h), (k) in (1) poglavja II Priloge I
Annex I, Chapter III, point 15 (b),
točka 15(b) poglavja III Priloge I
Council Directive 77/99:
Direktiva Sveta 77/99/EGS:
Annex A, Chapter I, point 2 (a), (b), (c), (d), (e), (f) and (g)
točka 2(a), (b), (c), (d), (e), (f) in (g) poglavja I Priloge A
Annex B, Chapter I, point 1 (a), (d), (e) and (f)
točka 1(a), (d), (e) in (f) poglavja I Priloge B
Annex B, Chapter I, point 2 (d), (e), (h), and (i)
točka 2(d), (e), (h) in (i) poglavja I Priloge B
UAB “Stragutės mėsa”
UAB ‚Stragutės mėsa‘
Annex I, Chapter III, point 15 (b)
točka 15(b) poglavja III Priloge I
Annex B,Chapter I, point 2 (a), (b) and (j)
točka 2(a), (b) in (j) poglavja I Priloge B
AB “Grabupėliai”
AB ‚Grabupėliai‘
Annex I, Chapter III, point 15 (b) and (d)
točka 15(b) in (d) poglavja III Priloge I
Annex I, Chapter IV, point 16 (a)
točka 16(a) poglavja IV Priloge I
Annex A, Chapter I, point 2 (a), (b), (c), (d), (e), (f), and (g)
točka 2(a), (b), (c), (d), (e), (f) in (g) poglavja I Priloge A
Annex B, Chapter I, point 1 (a) and (f)
točka 1(a) in (f) poglavja I Priloge B
Annex B, Chapter I, point 2 (c), (d), (i) and (j)
točka 2(c), (d), (i) in (j) poglavja I Priloge B
UAB “Rukesa ir ko”
UAB ‚Rukesa ir ko‘
Annex I, Chapter I, point 1 (a), (b), (c), (e), (f) and (g)
točka 1(a), (b), (c), (e), (f) in (g) poglavja I Priloge I
Annex B, Chapter I, point 2 (c), (d), (e) and (h)
točka 2(c), (d), (e) in (h) poglavja I Priloge B
LC-Meat products establishments
Obrati za predelavo mesa nizkih zmogljivosti
Annex I, Chapter I, point 1 (c) and (e)
točka 1(c) in (e) poglavja I Priloge I
Annex A, Chapter I, point 2 (b), (c), (d), (e) and (g)
točka 2(b), (c), (d), (e) in (g) poglavja I Priloge A
Annex A, Chapter I, points 3, 4, 6, 11, 12, 13 and 14
točke 3, 4, 6, 11, 12, 13 in 14 poglavja I Priloge A
Annex B, Chapter I, point 1 (a), (d) and (e)
točka 1(a), (d) in (e) poglavja I Priloge B
Annex B, Chapter I, point 2 (a), and (j)
točka 2(a) in (j) poglavja I Priloge B
Date of compliance
Datum usklajenosti
UAB “Kužių agroįmonė”, Kužių k., Šiaulių r., Šiaulių aps.
UAB ‚Kužių agroįmonė‘, Kužių k., Šiaulių r., Šiaulių aps.
ŽŪK “Getautų ūkininkas”, Getautų k., Pakruojo r., Šiaulių aps.
ŽŪK ‚Getautų ūkininkas‘, Getautų k., Pakruojo r., Šiaulių aps.
UAB “Norpa”, Šapnagių k., Akmenės r., Šiaulių aps.
UAB ‚Norpa‘, Šapnagių k., Akmenės r., Šiaulių aps.
UAB “Ropokalnis”, Žvejų g. 2, Šeduva, Radviliškio r., Šiaulių aps.
UAB ‚Ropokalnis‘, Žvejų g. 2, Šeduva, Radviliškio r., Šiaulių aps.
UAB “Cesta”, Žemoji Riešė, Vilniaus r., Vilniaus aps
UAB ‚Cesta‘, Žemoji Riešė, Vilniaus r., Vilniaus aps
UAB “Geras skonis”, Alionių k., Ukmergės r., Vilniaus aps.
UAB ‚Geras skonis‘, Alionių k., Ukmergės r., Vilniaus aps.
UAB “Sasnelė”, Bitikų k. Sasnavos sen., Marijampolės sav., Marijampolės aps.
UAB ‚Sasnelė‘, Bitikų k. Sasnavos sen., Marijampolės sav., Marijampolės aps.
ŽŪB “Delikatesas”, Kudirkos g. 2, Joniškio r., Šiaulių aps.
ŽŪB ‚Delikatesas‘, Kudirkos g. 2, Joniškio r., Šiaulių aps.
ŽŪK “Mikoliškio paukštynas”, Mykoliškio k., Pasvalio r., Panevėžio aps.
ŽŪK ‚Mikoliškio paukštynas‘, Mykoliškio k., Pasvalio r., Panevėžio aps.
Fish Establishments
Obrati za predelavo rib
UAB “Myxum”
UAB ‚Myxum‘
Annex, Chapter III.I, point 2 (a), (c), (d), (e) and (h)
točka 2(a), (c), (d), (e) in (h) poglavja III.I Priloge
Milk Establishments
Obrati za predelavo mleka
UAB “Kelmės pieninė”
UAB ‚Kelmės pieninė‘
Annex B, Chapter I, point 2 (a), (b), (c), (d), (e), (f) and (g)
točka 2(a), (b), (c), (d), (e), (f) in (g) poglavja I Priloge B
concerning a financial contribution by the Community in the context of the vaccination campaigns against bluetongue in France in 2004 and 2005
o finančnem prispevku Skupnosti v okviru cepljenja proti bolezni modrikastega jezika leta 2004 in 2005 v Franciji
(notified under document number C(2005) 3445)
(notificirano pod dokumentarno številko K(2005) 3445)
Having regard to Council Directive 2000/75/EC of 20 November 2000 laying down specific provisions for the control and eradication of bluetongue [1], and in particular Article 9(2) thereof,
ob upoštevanju Direktive Sveta 2000/75/ES z dne 20. novembra 2000 o določitvi posebnih določb za boj zoper in izkoreninjenje bolezni modrikastega jezika [1], in zlasti člena 9(2),
Having regard to Council Decision 90/424/EEC of 26 June 1990 on expenditure in the veterinary field [2], and in particular Article 3(3), (4) and (5), second indent, thereof,
ob upoštevanju Odločbe Sveta 90/424/EGS z dne 26. junija 1990 o odhodkih na področju veterine [2], in zlasti druge alinee člena 3(3), (4) in (5) Odločbe,
Outbreaks of bluetongue have occurred in France, and more particularly in Corsica, since the year 2000.
Od leta 2000 se je bolezen modrikastega jezika pojavljala v Franciji in še zlasti na Korziki.
On 13 September 2004 France declared new outbreaks of bluetongue in Corsica.
septembra 2004 je Francija prijavila nove izbruhe bolezni modrikastega jezika na Korziki.
The presence of serotypes 2, 4 and 16 was confirmed.
Potrjena je bila navzočnost serotipov 2, 4 in 16.
Outbreaks of bluetongue represent a serious risk to the Community’s livestock population.
Izbruhi bolezni modrikastega jezika so resna nevarnost za živino Skupnosti.
The virus continues to circulate and the protection provided by the vaccine lasts for only one year, therefore vaccination against bluetongue must be repeated each year in order to block the progression of the epidemic.
Virus se še naprej širi in zaščita s cepljenjem traja le eno leto, zato je treba cepljenje proti bolezni modrikastega jezika ponoviti vsako leto, da bi zajezili napredovanje epidemije.
Due to the evolution of the disease, it is therefore advisable to implement a vaccination campaign in the protection zones established around outbreaks of bluetongue.
Zaradi razvoja stanja bolezni je koristno, da se izvede akcija cepljenja v okuženih območjih okoli izbruhov.
Vaccination is a measure which, employed in combination with the measures already adopted, makes it possible to:
Cepljenje je ukrep, ki poleg že sprejetih ukrepov omogoča:
France has presented a vaccination plan which involves the use of the new inactivated vaccine (serotype 2) now available.
Francija je predstavila načrt cepljenja, ki predvideva uporabo novega inaktiviranega cepiva (serotip 2), ki je že na razpolago.
On 23 November 2004 France submitted a claim for reimbursement of the expenditure incurred in connection with the vaccination campaign.
novembra 2004 je Francija dala zahtevek za povračilo stroškov cepljenja proti bolezni.
According to the information available, approximately 300000 doses of inactivated vaccine (serotype 2) were purchased.
Po razpoložljivih informacijah je bilo kupljenih 300000 doz inaktiviranega cepiva serotipa 2.
The financial contribution from the Community must be 100 % of the cost of supply of the vaccine and 50 % of the costs incurred in carrying out the vaccination.
Finančni prispevek Skupnosti mora biti 100 % stroška preskrbe s cepivom in 50 % stroškov za izvedbo cepljenja.
Pending checks by the Commission, it is now necessary to set the amount for payment of the first instalment of the Community financial assistance.
Preden bo Komisija izvedla preverjanje, je že zdaj treba določiti znesek vplačila prvega obroka finančne pomoči Skupnosti.
The payment of the financial contribution from the Community must be subject to the condition that the actions planned have actually been carried out and that the authorities supply all the necessary information within the time limits laid down.
Za vplačilo finančnega prispevka Skupnosti veljata pogoja, da so bili načrtovani ukrepi dejansko izvedeni in da organi predložijo vse potrebne podatke v določenih rokih.
The French authorities have fulfilled all their technical and administrative obligations with regard to the measures provided for in Article 3 of Decision 90/424/EEC.
Francoski organi so v celoti izpolnili svoje tehnične in administrativne obveznosti glede ukrepov iz člena 3 Odločbe Sveta 90/424/EGS.
The bluetongue vaccination campaign implemented by France in Corsica, in the zones listed in Annex I to Decision 2005/393/EC, is approved.
Akcija cepljenja proti bolezni modrikastega jezika, ki jo na Korziki izvaja Francija na območjih, navedenih v Prilogi I k Odločbi 2005/393/ES, se odobri.
Granting of a financial contribution from the Community to France
Dodelitev finančnega prispevka Skupnosti Franciji
For the purposes of combating bluetongue in 2004 and during the first half of 2005, France is entitled, for the campaign of vaccination against bluetongue in Corsica, to a financial contribution from the Community amounting to:
Za boj proti bolezni modrikastega jezika v letu 2004 in za prvo polovico leta 2005 lahko Francija dobi za cepljenje proti bolezni modrikastega jezika na Korziki finančni prispevek Skupnosti, ki znaša:
100 % of the costs incurred (not including VAT) in purchasing 300000 doses of inactivated serotype 2 vaccine,
100 % nastalih stroškov (brez DDV) za nakup 300000 doz inaktiviranega cepiva serotipa 2,
50 % of the costs of salaries and fees paid to personnel specifically employed to carry out the vaccinations, and 50 % of the cost (not including VAT) of the expenditure directly associated with the vaccinations (consumables and small items of equipment).
50 % stroškov za plače in honoraje, izplačane osebju, posebej zaposlenemu za to cepljenje, kakor tudi stroškov (brez DDV) odhodkov, neposredno povezanih z izvajanjem cepljenja (potrošno blago in drobni material).
The following definition applies to this Decision:
V tej odločbi se uporablja naslednja opredelitev:
‘reasonable payments’ means payments for the purchase of materials or services at proportionate prices compared to the market prices before the vaccination campaign.
„Primerna plačila“: plačila za nakup materiala ali storitev po sorazmernih cenah v primerjavi s tržnimi cenami, ki so veljale pred akcijo cepljenja.
Subject to the results of the inspections referred to in Article 7, an initial instalment of EUR 150000 shall be paid, as part of the Community financial contribution mentioned in Article 2, on the basis of supporting documents submitted by France relating to the vaccination of animals.
Ob upoštevanju rezultatov morebitnih preverjanj iz člena 7 se prvi obrok 150000 EUR izplača kot finančni prispevek Skupnosti iz člena 2 na podlagi dokazil o cepljenju živali, ki jih predloži Francija.
The eligible expenditure covered by the financial contribution from the Community
Upravičeni odhodki, pokriti s finančnim prispevkom Skupnosti
The financial contribution from the Community as referred to in Article 2 shall only be made in respect of justified and reasonable payments relating to the authorised expenditure mentioned in Article 2.
Finančni prispevek Skupnosti, določen v členu 2, se nakaže samo v primeru primernih plačil ter upravičenih glede na dovoljene odhodke iz člena 2.
The financial contribution from the Community as referred to in Article 2 shall be paid on the basis of:
Finančni prispevek Skupnosti iz člena 2 se plača na podlagi:
an application submitted, in accordance with the Annex, within the time limit laid down in paragraph 2;
zahteve, ki se predloži v skladu s Prilogo, v roku iz odstavka 2;
the supporting documents referred to in Article 2, including an epidemiological report on each holding where animals have been vaccinated;
dokazil o odhodkih, navedenih v členu 2 vključno z epidemiološkim poročilom o vsakem gospodarstvu, kjer so bile živali cepljene;
the results of any in situ inspections carried out by the Commission, as referred to in Article 7.
rezultatov vsake inšpekcije Komisije na mestu samem, kakor je določeno v členu 7.
The documents referred to at (b) shall be made available for on-the-spot audits by the Commission.
Dokumenti iz točke (b) zgoraj morajo biti predloženi Komisiji v revizijo na mestu samem.
The application referred to in paragraph 1(a) must be submitted in computerised form, in accordance with the Annexes, within 60 calendar days of the date of notification of this Decision.
Zahtevek iz odstavka 1(a) mora biti predložen v računalniški obliki v skladu s Prilogo v roku šestdeset koledarskih dni od dneva uradnega obvestila o tej odločbi.
If this time limit is not observed, the financial contribution from the Community shall be reduced by 25 % for every month of delay.
Če se rok ne bo upošteval, bo finančni prispevek Skupnosti zmanjšan za 25 % za vsak mesec zamude.
The Commission, in collaboration with the competent French authorities, may conduct in situ inspections relating to the implementation of the measures referred to in Article 1 and the associated costs.
Komisija lahko v zvezi z izvajanjem ukrepov iz člena 1 in odhodkov s tem v zvezi v sodelovanju s pristojnimi francoskimi organi izvaja preverjanja na kraju samem.
Decision as last amended by Decision 2005/603/EC (OJ L 206, 9.8.2005, p. 11).
Odločba, kakor je bila nazadnje spremenjena z Odločbo 2005/603/ES (UL L 206, 9.8.2005, str. 11).
Application for a contribution towards the eligible costs associated with the bluetongue vaccination campaign
Zahtevek za prispevek k upravičenim stroškom v okviru akcije cepljenja proti bolezni modrikastega jezika
Amount (not including VAT)
Znesek (brez DDV)
OJ L 224, 18.8.1990, p. 19. Decision as last amended by Directive 2003/99/EC of the European Parliament and of the Council (OJ L 325, 12.12.2003, p. 31).
UL L 224, 18.8.1990, str. 19, Odločba, kakor je bila nazadnje spremenjena z Direktivo 2003/99/ES Evropskega parlamenta in Sveta (UL L 325, 12.12.2003, str. 31).
concerning a financial contribution by the Community in the context of the emergency measures taken to combat bluetongue in Portugal in 2004 and 2005
o finančnem prispevku Skupnosti v okviru izrednih ukrepov za boj proti bolezni modrikastega jezika na Portugalskem v letih 2004 in 2005
(notified under document number C(2005) 3446)
(notificirano pod dokumentarno številko K(2005) 3446)
Having regard to Council Decision 90/424/EEC of 26 June 1990 on expenditure in the veterinary field [2], and in particular Article 3(3), (4) and (5), second indent, and Article 5(3) thereof,
ob upoštevanju Odločbe Sveta 90/424/EGS z dne 26. junija 1990 o odhodkih na področju veterine [2], in zlasti druge alinee člena 3(3), (4), (5) in člena 5(3) Odločbe,
On 24 November 2004, outbreaks of bluetongue appeared in Portugal.
novembra 2004 je bolezen modrikastega jezika izbruhnila na Portugalskem.
The emergence of this disease represents a serious risk to the Community’s livestock population.
Pojav te bolezni predstavlja resno nevarnost za živinorejo Skupnosti.
In order to prevent the spread of the disease as rapidly as possible, the Community must contribute financially to the eligible expenditure incurred by the Member State in the context of the emergency measures taken to combat the disease, as provided for in Decision 90/424/EEC.
Z namenom preprečiti širjenje bolezni v najkrajšem možnem času mora Skupnost finančno prispevati k upravičenim izdatkom, ki nastanejo v državah članicah zaradi izrednih ukrepov, sprejetih v boju proti tej bolezni, kot določa Odločba 90/424/EGS.
Various decisions, notably the latest one, Decision 2005/393/EC of 23 May 2005 on protection and surveillance zones in relation to bluetongue and conditions applying to movements from or through these zones [3], have been adopted by the Commission in order to demarcate the protection and surveillance zones and to set out the conditions governing movements of animals from these zones.
Razne odločbe, zlasti zadnjo, to je Odločba 2005/393/ES z dne 23. maja 2005 o okuženih in ogroženih območjih zaradi bolezni modrikastega jezika in o pogojih, ki veljajo za premike s teh območij ali prek teh območij [3], je Komisija sprejela z namenom, da se določijo okužena in ogrožena območja ter da se določijo pogoji, katere morajo izpolnjevati živali ob premiku s teh območij.
Bluetongue is a disease transmitted exclusively by ‘mosquitoes’, therefore the only measures which are apposite, of all those provided for in Article 3(2) of Decision 90/424/EEC, are those aimed either at protecting animals against attacks from the vectors (treatment with insecticides, confining the animals indoors at the times when the vectors are active) or at preventing the spread of the epidemic through movements of animals (Decision 2005/393/EC).
Bolezen modrikastega jezika se prenaša izključno s „komarji“, zato so med vsemi ukrepi, predvidenimi v členu 3(2) Odločbe 90/4244/EGS, primerni tisti, ki so usmerjeni k zaščiti živali pred napadi prenašalcev bolezni (uporaba insekticidov, zapiranje živali v zaprte prostore ob času, ko so prenašalci aktivni) ali preprečevanje širjenja bolezni s premiki živali (Odločba 2005/393/ES).
The slaughter of animals of susceptible species is not an apposite measure except in the case of animals clinically affected with bluetongue.
Zakol živali občutljivih vrst ni primeren ukrep, razen kadar so živali klinično okužene.
Due to the evolution of the disease, it is advisable to implement a vaccination campaign in the protection zones established around outbreaks of bluetongue.
Zaradi ocene stanja bolezni je primerno, da se opravi akcija cepljenja na vseh ogroženih območjih okrog katerih je izbruhnila bolezen.
Vaccination is a measure which, employed in combination with apposite eradication measures, makes it possible to:
Cepljenje je ukrep, ki skupaj z ukrepi izkoreninjenja omogoča:
In accordance with Article 3(2) of Council Regulation (EC) No 1258/1999 of 17 May 1999 on the financing of the common agricultural policy [4], veterinary and plant health measures undertaken in accordance with Community rules are financed by the ‘Guarantee’ section of the European Agricultural Guidance and Guarantee Fund.
V skladu s členom 3(2) Uredbe Sveta (ES) št. 1258/1999 z dne 17. maja 1999 o financiranju skupne kmetijske politike [4] se veterinarski ukrepi in ukrepi zdravstvenega varstva rastlin, sprejeti v skladu s skupnimi pravili Skupnosti, financirajo iz jamstvenega oddelka Evropskega kmetijskega usmerjevalnega in jamstvenega sklada.
The auditing of these measures comes under Articles 8 and 9 of the said Regulation.
Za namene finančnega nadzora je treba uporabljati člena 8 in 9 navedene uredbe.